Lipidomic Analysis Reveals Alterations in Hepatic FA Profile Associated With MASLD Stage in Patients With Obesity.

María Ángeles Núñez-SánchezMaría Antonia Martínez-SánchezJosé Ignacio Martínez-MontoroAndrés Balaguer-RománElena Murcia-GarcíaVirginia Esperanza Fernández-RuizMercedes Ferrer-GómezCarlos Manuel Martínez-CáceresTomasz SledzinskiMaría Dolores FrutosJuan José Hernández-MoranteJosé Carlos Fernández-GarcíaMaría Isabel Queipo-OrtuñoAntonio José Ruiz-AlcarazAdriana Mika Bruno Ramos-Molina

Published in: The Journal of clinical endocrinology and metabolism (2024)

Alterations in hepatic FA levels in MASLD patients were due to enhancement of de novo lipogenesis in the liver.

Keyphrases

end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
metabolic syndrome
insulin resistance
type diabetes
weight loss
high fat diet induced
prognostic factors
patient reported outcomes
skeletal muscle
physical activity